Oticon Medical
Clinical trials sponsored by Oticon Medical, explained in plain language.
Hearing implant manufacturer, part of the Demant group.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hearing implant trial aims to help kids hear better Results expected Oct 2026 (estimated)
- Which bone conduction hearing device works best? new study aims to find out. Results expected Oct 2026 (estimated)
- Hearing implants without the OR: a safer, simpler approach? Results expected Mar 2027 (estimated)
- New hearing device for teens: can it restore sound? Results expected Apr 2027 (estimated)
-
New minimally invasive ear implant surgery shows promise for hearing loss
Symptom relief CompletedThis study tested a new, less invasive surgical method for placing a bone-anchored hearing device (Ponto implant) in 52 adults with hearing loss. The goal was to see if the implant stayed securely in place without causing skin problems or pain. The approach aims to make the proce…
Sponsor: Oticon Medical • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New sound processor boosts hearing in small trial
Symptom relief CompletedThis study tested a new sound processor (Sentio 1) for people with conductive or mixed hearing loss who already have a bone-anchored implant. Eleven adults participated, and the main goal was to see how much their hearing improved with the device. The results showed measurable he…
Sponsor: Oticon Medical • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC